Cardiovascular Outcomes Trials in Type 2 Diabetes Mellitus | Citedby Results | Cardiology | Karger Publishers

Skip to Main Content

Skip Nav Destination

Cardiovascular Outcomes Trials in Type 2 Diabetes Mellitus

Cardiology (2016) 135 (2): 108–126.

This article has been cited by the following articles in journals that are participating in CrossRef Cited-by Linking.

Cardiovascular Comorbidities Are the Main Predictors of Cardiac Reverse Remodeling following Kidney Transplantation

Masatake Kobayashi
Olivier Huttin
Johan Schikowski
Erwan Bozec
Lamiral Zohra
Luc Frimat
Nicolas Girerd
Sophie Girerd

Cardiology (2020) 145 (2): 71.

When and how to Use Ultralong-Acting Basal Insulin in T2Dm

Alan J. Garber

Endocrine Practice (2016) 22: 9.

When and how to Use A Glp-1 ra With Long- or Ultralong-Acting Basal Insulin in T2Dm

Bruce Bode

Endocrine Practice (2016) 22: 14.

When and how to Use Prandial Insulin with Ultralong-Acting Basal Insulin in T2Dm

Guillermo E. Umpierrez

Endocrine Practice (2016) 22: 12.

The History of Insulin Technology: A Brief Review of the Updates in Basal Insulin Therapy Through the Years

Alan J. Garber

Endocrine Practice (2016) 22: 7.